Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TARO-IMATINIB DIN 02428318

Status: Approved
Holder: SUN PHARMA CANADA INC
Molecule: IMATINIB (IMATINIB MESYLATE)

Health Canada record

Active ingredient(s)IMATINIB (IMATINIB MESYLATE) 100 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EA01 IMATINIB
Original market date
Current status date24-Apr-2023
SourceHealth Canada DPD

Establishment licence of the holder

Sun Pharma Canada Inc. — licence 3-002572, currently licensed, last inspection rating C (2026-06-15).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing IMATINIB (IMATINIB MESYLATE)

DINProductCompanyFormStrengthStatus
02490986ACH-IMATINIBACCORD HEALTHCARE INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02490994ACH-IMATINIBACCORD HEALTHCARE INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02355337APO-IMATINIBAPOTEX INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02355345APO-IMATINIBAPOTEX INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02253275GLEEVECNOVARTIS PHARMACEUTICALS CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02253283GLEEVECNOVARTIS PHARMACEUTICALS CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02521210IMATINIBSIVEM PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02504596IMATINIBSANIS HEALTH INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02504618IMATINIBSANIS HEALTH INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02521202IMATINIBSIVEM PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02492342MINT-IMATINIBMINT PHARMACEUTICALS INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02492334MINT-IMATINIBMINT PHARMACEUTICALS INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02397293NAT-IMATINIBNATCO PHARMA (CANADA) INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02397285NAT-IMATINIBNATCO PHARMA (CANADA) INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02428326TARO-IMATINIBSUN PHARMA CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGApproved
02399814TEVA-IMATINIBTEVA CANADA LIMITEDTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02399806TEVA-IMATINIBTEVA CANADA LIMITEDTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02244725GLEEVECNOVARTIS PHARMACEUTICALS CANADA INCCapsuleIMATINIB (IMATINIB MESYLATE) 100 MGCancelled Post Market
02495066JAMP IMATINIBJAMP PHARMA CORPORATIONTabletIMATINIB (IMATINIB MESYLATE) 100 MGDormant
02495074JAMP IMATINIBJAMP PHARMA CORPORATIONTabletIMATINIB (IMATINIB MESYLATE) 400 MGDormant
02424495MYLAN-IMATINIBMYLAN PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 100 MGCancelled Pre Market
02424509MYLAN-IMATINIBMYLAN PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 400 MGCancelled Pre Market
02431122PMS-IMATINIBPHARMASCIENCE INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGDormant
02431114PMS-IMATINIBPHARMASCIENCE INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGDormant
02515547SANDOZ IMATINIBSANDOZ CANADA INCORPORATEDTabletIMATINIB (IMATINIB MESYLATE) 100 MGCancelled Pre Market
02515555SANDOZ IMATINIBSANDOZ CANADA INCORPORATEDTabletIMATINIB (IMATINIB MESYLATE) 400 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
305592023-04-24Abbreviated New Drug Submission (ANDS)Administrative: Manufacturer and Product Name Change. Update to the Product Monograph and Labels
158162014-07-16Abbreviated New Drug Submission (ANDS)
Request a quote for TARO-IMATINIB

How to read a Canadian DIN record